ReguPrep Free preview

Official sources are linked where cited · Preliminary guidance; no qualified legal or regulatory review. Editorial method and review status

STRUCTURE/FUNCTION CLAIMS

Review the FDA disclaimer with the complete claim context

A disclaimer does not repair a disease claim or prove that a structure/function claim is substantiated. Classify the exact wording first, then review the statutory disclaimer, presentation, notification, and evidence together.

Open the claims checker

Check DSHEA disclaimer text

One statement, multiple statements and label placement

For covered dietary supplement statements, 21 CFR 101.93(c) distinguishes the singular disclaimer below from the plural version. A general product advertisement is not automatically within this supplement route.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Presentation questionSaved rule text to check
Next to a covered statementAdjacent, with no intervening material, or linked by a matching symbol at the end of each statement.
Different panels or pagesThe regulation retains the panel/page wording. Review the FDA enforcement policy below for product-label panels; do not assume a waiver for other labeling pages. When not adjacent, review the box requirement.
Physical type sizeParagraph (e) requires boldface letters no smaller than 1/16 inch. A CSS size or enlarged PDF is not a physical print measurement.

Layout-only example: Claim A* and Claim B* on one panel point to the same * beside the boxed plural disclaimer on that panel. Review other panels in light of the FDA enforcement policy below. This schematic does not establish that either claim is permissible or substantiated.

21 CFR 101.93(c)–(e), saved October 6 snapshot

The regulation still contains a panel/page requirement. FDA announced enforcement discretion on December 11, 2025 for repeating the disclaimer on every claim-bearing product-label panel; the letter does not waive inclusion on the label, linkage to each claim or other requirements. Do not extend this policy to every page of other labeling.

FDA DSHEA disclaimer enforcement policy

The statutory disclaimer text

“This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.”

21 CFR 101.93 contains presentation rules for this disclaimer. When a label or labeling contains more than one covered statement, the regulation also addresses how the disclaimer may be linked to the statements. Review the current text before final artwork approval.

Four separate questions

  1. What does the statement communicate? Review express wording, implied meaning, product name, images, testimonials, audience, and nearby text.
  2. Is it a permissible type of claim? A disease claim does not become permissible merely because the disclaimer appears nearby.
  3. Is the statement substantiated? The manufacturer must have evidence supporting that the statement is truthful and not misleading.
  4. Were presentation and notification handled? Review the disclaimer under 21 CFR 101.93 and the notification requirement under section 403(r)(6) of the FD&C Act.

Preserve the relationship

Keep every claim body with its asterisk, symbol, footnote, qualifier, and panel location. This is especially important for OCR: extracting the sentence while losing the linked qualifier can change the apparent meaning. Review website, marketplace, advertising, and social copy separately because the label disclaimer does not automatically qualify every external statement.

Official starting points

Related guides

Editorial examples updated . Source-version limits remain unchanged; qualified professional review pending.